Actually, our result demonstrated that constitutive overexpression of ABCG2 in drug-resistant colon cancer cells SW1116/HCPT resulted in great resistance to chemotherapeutic drugs, although the underlying molecular mechanisms remained unknown in detail. This evidence concerns the gene ABCG2 and malignant colon neoplasm.